Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Subramaniam

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Transplantation|January 1, 1992
Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levelsB Li, P K Sehajpal, A Subramaniam, et al.
European Neurology|February 14, 2003
Survival of cardiac function after brain death in patients in KuwaitS Al-Shammri, R F Nelson, R Madavan, et al.
QJM : Monthly Journal of the Association of Physicians|June 8, 2018
Time to improve training for hypoxic pulmonary challenge testA Alameeri, M Ur Rasool, O Wynne, et al.
Contemporary Clinical Trials|September 27, 2016
Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97]Li-Tzy Wu, Jennifer McNeely, Geetha A Subramaniam, et al.
Ancient Science of Life|May 5, 2012
Further on the pharmacology of trichopus zeylanicusP Pushpangadan, S Rajasekharan, A Subramaniam, et al.
Contemporary Clinical Trials|July 23, 2016
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) toolLi-Tzy Wu, Jennifer McNeely, Geetha A Subramaniam, et al.
Drug and Alcohol Dependence|April 11, 2018
Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patientsWilliam S John, He Zhu, Paolo Mannelli, et al.
Addiction (Abingdon, England)|July 15, 2010
Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trialDaniel Polsky, Henry A Glick, Jianing Yang, et al.
QJM : Monthly Journal of the Association of Physicians|March 20, 2021
Therapeutic anti-coagulation in COVID-19 and the potential enhanced risk of retroperitoneal hematomaC Ottewill, R Mulpeter, J Lee, et al.
The Psychiatric Clinics of North America|October 25, 2023
National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent HealthGeetha A Subramaniam, Laura Nolan, Kristen Huntley, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Transplantation|January 1, 1992
Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levelsB Li, P K Sehajpal, A Subramaniam, et al.
European Neurology|February 14, 2003
Survival of cardiac function after brain death in patients in KuwaitS Al-Shammri, R F Nelson, R Madavan, et al.
QJM : Monthly Journal of the Association of Physicians|June 8, 2018
Time to improve training for hypoxic pulmonary challenge testA Alameeri, M Ur Rasool, O Wynne, et al.
Contemporary Clinical Trials|September 27, 2016
Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97]Li-Tzy Wu, Jennifer McNeely, Geetha A Subramaniam, et al.
Ancient Science of Life|May 5, 2012
Further on the pharmacology of trichopus zeylanicusP Pushpangadan, S Rajasekharan, A Subramaniam, et al.
Contemporary Clinical Trials|July 23, 2016
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) toolLi-Tzy Wu, Jennifer McNeely, Geetha A Subramaniam, et al.
Drug and Alcohol Dependence|April 11, 2018
Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patientsWilliam S John, He Zhu, Paolo Mannelli, et al.
Addiction (Abingdon, England)|July 15, 2010
Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trialDaniel Polsky, Henry A Glick, Jianing Yang, et al.
QJM : Monthly Journal of the Association of Physicians|March 20, 2021
Therapeutic anti-coagulation in COVID-19 and the potential enhanced risk of retroperitoneal hematomaC Ottewill, R Mulpeter, J Lee, et al.
The Psychiatric Clinics of North America|October 25, 2023
National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent HealthGeetha A Subramaniam, Laura Nolan, Kristen Huntley, et al.
Pageof 9